Studies on the circulating insulin inhibitor found in some diabetic patients exhibiting chronic insulin resistance.
Explore the source record for details and available documents.
Diabetes Mellitus↗
Biomedical subjects
J B FIELD
Publications and source records attributed to J B FIELD.
Circulating insulin antagonists in diabetes mellitus: untreated diabetics, diabetics during infections and acromegalics with diabetes.
Explore the source record for details and available documents.
Acromegaly↗
Relationship of structure to tumor-inhibitory activity in the phenanthrene series.
Explore the source record for details and available documents.
Animals↗
Failure of radioiodine to induce thyroid cancer in the rat.
Explore the source record for details and available documents.
Animals↗
Insulin binding in vitro by leukocytes from normal and diabetic subjects.
Explore the source record for details and available documents.
Diabetes Mellitus↗
New agents for inhibition of mouse tumors.
Explore the source record for details and available documents.
Animals↗
Further screening studies of new agents against sarcoma 180 in mice.
Explore the source record for details and available documents.
Animals↗
Interrelationship of chylomicron counts and ultracentrifuge fractionation of serum lipids.
Explore the source record for details and available documents.
Chemical Fractionation↗
Further characterization of an insulin antagonist in the serum of patients in diabetic acidosis.
Explore the source record for details and available documents.
Diabetes Complications↗
The carcinolytic effect of actinomycin C; a report of clinical studies.
Actinomycin C was administered to 35 patients with a variety of malignant states. There was no evidence of any toxic reaction. Of 11 patients with Hodgkins disease, four had brief objective remission ranging from two to four months. Individual patients with chronic myelogenous leukemia, multiple myeloma and neuroblastoma had short periods of clinical improvement. The usefulness of actinomycin C appears to be limited. It may best be used in instances of Hodgkin's disease where pancytopenia prevents the use of other agents.
Anti-Bacterial Agents↗
Oral preparations of antidiabetic agents; report of a fatal case.
Explore the source record for details and available documents.
Diabetes Mellitus↗
Humoral insulin antagonism associated with diabetic acidosis.
Explore the source record for details and available documents.
Complementary Therapies↗
Tyrosinase substrates and inhibitors studied colorimetrically.
Explore the source record for details and available documents.
Catechol Oxidase↗
Effect of oral hypoglycemic drug (carbutamide) on glycogen deposition by isolated rat hemidiaphragm.
Explore the source record for details and available documents.
Animals↗
The enzymatic hydrolysis of glucuronolactone.
Explore the source record for details and available documents.
Carbohydrate Metabolism↗
Oral mercurial diuretics: mercumatilin in the treatment of congestive heart failure.
Explore the source record for details and available documents.
Diuretics↗
Studies on glucuronide conjugation in man.
Explore the source record for details and available documents.
Carbohydrate Metabolism↗
Dipaxin: 2-diphenylacetyl-1,3-indandione; clinical evaluation of a new anticoagulant.
Explore the source record for details and available documents.
Anticoagulants↗